We are live on ! Find out more
HL

Harding Loevner Portfolio holdings

AUM $9.72B
1-Year Est. Return 22.38%
This Fund
S&P 500
This Quarter Est. Return
+0.18%
1 Year Est. Return
+22.38%
3 Year Est. Return
+79.36%
5 Year Est. Return
+98.01%
10 Year Est. Return
+375.62%
AUM
$13.5B
AUM Growth
+$101M
Cap. Flow
+$252M
Cap. Flow %
1.86%
Top 10 Hldgs %
31.95%
Holding
88
New
3
Increased
33
Reduced
39
Closed
3

Top Sells

Rank Stock Value
1
QGENF
QIAGEN NV
QGENF
+$120M
2
WFC icon
Wells Fargo
WFC
+$78.6M
3
PX
Praxair Inc
PX
+$44.7M
4
BG icon
Bunge Global
BG
+$37.9M
5
KOF icon
Coca-Cola Femsa
KOF
+$34.3M

Sector Composition

Rank Sector Weight
1 Financials 20.69%
2 Technology 15.88%
3 Energy 10.04%
4 Consumer Staples 9.3%
5 Healthcare 9.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCFS icon
76
FirstCash
FCFS
$8.78B
$897K 0.01%
16,020
PCP
77
DELISTED
PRECISION CASTPARTS CORP
PCP
$351K ﹤0.01%
1,480
ALL icon
78
Allstate
ALL
$67.5B
$188K ﹤0.01%
3,058
NBL
79
DELISTED
Noble Energy, Inc.
NBL
$109K ﹤0.01%
1,600
ELV icon
80
Elevance Health
ELV
$85.5B
$96K ﹤0.01%
800
JNJ icon
81
Johnson & Johnson
JNJ
$625B
$85K ﹤0.01%
800
ITW icon
82
Illinois Tool Works
ITW
$84.5B
$68K ﹤0.01%
800
GRFS
83
Grifois
GRFS
$5.4B
$53K ﹤0.01%
3,000
AVY icon
84
Avery Dennison
AVY
$13.4B
$27K ﹤0.01%
600
RIG icon
85
Transocean
RIG
$5.82B
$7K ﹤0.01%
218
IFF icon
86
International Flavors & Fragrances
IFF
$21.9B
-105
Closed -$11K
KOF icon
87
Coca-Cola Femsa
KOF
$23.2B
-302,156
Closed -$34.3M
TROW icon
88
T. Rowe Price
TROW
$24.3B
-167,184
Closed -$14.1M

Similar funds

Harding Loevner's Q3 2014 Portfolio in Review

As of Q3 2014, Harding Loevner held 88 positions worth $13.5B, up 0.75% from $13.4B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Harding Loevner's Q3 2014 filing shows 3 new, 33 increased, 39 reduced and 3 closed positions. Its largest new stake was AbbVie: 2,998,750 shares worth $173M. The largest sale was QIAGEN NV, an estimated $120M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Technology and Energy.

  • Harding Loevner's largest Q3 2014 buy was AbbVie: 2,998,750 shares worth $173M.
  • Harding Loevner added most to Mastercard in Q3 2014, an estimated $139M increase.
  • Harding Loevner's biggest Q3 2014 reduction was QIAGEN NV, cutting an estimated $120M.
  • Harding Loevner fully exited Coca-Cola Femsa in Q3 2014, selling an estimated $34.3M.
  • Harding Loevner's ten largest holdings make up 32% of its $13.5B portfolio in Q3 2014.
  • Harding Loevner opened 3 new positions and closed 3 in Q3 2014.
  • Harding Loevner's portfolio value rose 0.75% quarter-over-quarter to $13.5B.

Based on Harding Loevner's 13F filing for Q3 2014, filed 31 Oct 2014.